← Eichor
Study identifier: NCT07345091 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Feasibility Performance Study of ABL90 FLEX PLUS HEM

Condition: Hemolysis  ·  Sponsor: Radiometer Medical ApS

PhaseN/A
Planned participants95
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This feasibility performance study evaluates the ABL90 FLEX PLUS HEM device for its analytical performance in a clinical setting. The study aims to evaluate the performance of the hemolysis detection feature.

This description comes directly from the study's public registry record.

Talk to the study team

Vadim Fedulov  ·  +4526311594  ·  vadim.fedulov@radiometer.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Bispebjerg HospitalCopenhagen, NV, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07345091